Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis

This publication has 29 references indexed in Scilit:

• Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization‐defined chromosome 13 deletion in multiple myeloma: early results of total therapy II
  British Journal of Haematology, 2002
• Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality
  Blood, 2002
• Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
  Blood, 2002
• Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy
  Blood, 2002
• Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the Duet™ (BioView) combined morphological and cytogenetical analysis
  Leukemia, 2002
• Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet™) combined morphological and cytogenetical analysis
  Leukemia, 2002
• Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
  Blood, 2001
• Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
  New England Journal of Medicine, 1999
• Combined Morphological and Interphase Fluorescence in Situ Hybridization Study in Multiple Myeloma of Chinese Patients
  The American Journal of Pathology, 1999
• THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS
  Annual Review of Genetics, 1998